| Assay ID | Title | Year | Journal | Article |
|---|
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID70620 | Antibacterial activity against enteropathogenic Escherichia coli ATCC 25922 was determined after 24 hr | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID241327 | Inhibitory concentration against Methionine aminopeptidase-1 (EcMetAP1) | 2005 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
| Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 2: SAR studies on the pyridine ring 3-substituent. |
| AID489473 | Inhibition of human MetAP1 at 25 uM | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID489475 | Inhibition of human MetAP2 expressed in baculovirus infected Sf9 cells at 25 uM | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID247687 | Inhibitory concentration required against Escherichia coli MetAP1 (150 nM) | 2005 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 15, Issue:16
| Identification of potent type I MetAP inhibitors by simple bioisosteric replacement. Part 1: Synthesis and preliminary SAR studies of thiazole-4-carboxylic acid thiazol-2-ylamide derivatives. |
| AID107922 | Selectivity of inhibitory activity of Methionine aminopeptidase 1 from Escherichia coli to Methionine aminopeptidase 1 from Saccharomyces cerevisiae | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID489474 | Inhibition of human MetAP1 | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID163954 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 was determined after 24 hr | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID240896 | Inhibitory concentration against ScMetAP1 enzyme activity | 2005 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
| Identification of potent type I MetAPs inhibitors by simple bioisosteric replacement. Part 2: SAR studies of 5-heteroalkyl substituted TCAT derivatives. |
| AID489470 | Inhibition of Escherichia coli MetAP | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID240890 | Inhibitory concentration against EcMetAP1 enzyme activity | 2005 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
| Identification of potent type I MetAPs inhibitors by simple bioisosteric replacement. Part 2: SAR studies of 5-heteroalkyl substituted TCAT derivatives. |
| AID489471 | Inhibition of Staphylococcus aureus MetAP at 25 uM | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID241787 | Inhibitory concentration against Saccharomyces cerevisiae methionine aminopeptidase 1 | 2005 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
| Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 1: SAR studies on the determination of the key scaffold. |
| AID207551 | Antibacterial activity against Staphylococcus aureus ATCC 25923 was determined after 24 hr | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID489476 | Inhibition of human MetAP2 expressed in baculovirus infected Sf9 cells | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID107916 | Inhibitory activity against type I methionine aminopeptidase from Saccharomyces cerevisiae | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID241328 | Inhibitory concentration against Methionine aminopeptidase-1 (ScMetAP1) | 2005 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
| Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 2: SAR studies on the pyridine ring 3-substituent. |
| AID247875 | Inhibitory concentration required against Saccharomyces cerevisiae MetAP1 (330 nM) | 2005 | Bioorganic & medicinal chemistry letters, Aug-15, Volume: 15, Issue:16
| Identification of potent type I MetAP inhibitors by simple bioisosteric replacement. Part 1: Synthesis and preliminary SAR studies of thiazole-4-carboxylic acid thiazol-2-ylamide derivatives. |
| AID241532 | Inhibitory concentration against Escherichia coli methionine aminopeptidase 1 | 2005 | Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
| Inhibitors of type I MetAPs containing pyridine-2-carboxylic acid thiazol-2-ylamide. Part 1: SAR studies on the determination of the key scaffold. |
| AID107914 | Inhibitory activity against Methionine aminopeptidase 1 from Escherichia coli | 2003 | Journal of medicinal chemistry, Jun-19, Volume: 46, Issue:13
| Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. |
| AID489469 | Inhibition of Escherichia coli MetAP at 25 uM | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| AID489472 | Inhibition of Staphylococcus aureus MetAP | 2010 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
| Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |